On ECHEMI
Home > Drugs > Preterm birth
Preterm birth
In 1935, the American Academy of Pediatrics proposed that any live birth with a weight of 2500g or less is considered premature. In the subsequent clinical application process, people realized that there can be a large difference between gestational age and actual fetal weight when fetal growth is restricted. Therefore, in 1961, the World Health Organization established a standard for gestational age for premature birth, defining births of those who gave birth at less than 37 weeks of gestation as premature, but did not set a lower limit. There is no unified definition of premature birth at home and abroad. At present, my country defines premature birth as births of 28 to less than 37 weeks of gestation, calculated from the first day of the last menstrual period. People divide premature births into three categories based on gestational age: 1. Extreme premature births occur between 20 and 28 weeks of gestation, accounting for 5%. 2. Early premature births occur at <32 weeks of gestation, accounting for 10%. 3. Premature births between 32 and 36 weeks of gestation are considered mild premature births, accounting for 85%. Some scholars further divide 32-36 weeks into two subgroups, calling premature births before 32-34 weeks moderate premature births, and premature births between 34 and 36 weeks mild premature births.
  • Site of disease:

    whole body
  • Infectious :

    Not contagious
  • Frequent population:

    Pregnant women between 28 and 37 weeks of pregnancy
  • Related symptoms:

    Cervical dilatation Threatened premature labor Premature rupture of membranes Vaginal bleeding Stomach ache
  • Concurrent disease:

Related Drugs
Vitamin E soft capsules
Indication: 1. For newborns, premature infants, and low birth weight infants born to mothers who do not eat fortified milk powder or have severe fat malabsorption. 2. Routine use of this product in immature infants and low birth weight infants can prevent hemolytic anemia caused by vitamin E deficiency, and can reduce the formation of retrobulbar fibrous tissue (which can cause blindness) and bronchial-pulmonary system dysplasia caused by oxygen poisoning. However, some people believe that the above effects need further research and confirmation. 3. For the adjuvant treatment of progressive muscular dystrophy.
Manufacturer:

PKU HealthCare Corp., Ltd.

Vitamin E soft capsules
Indication: 1. For newborns, premature infants, and low birth weight infants born to mothers who do not eat fortified milk powder or have severe fat malabsorption. 2. Routine use of this product in immature infants and low birth weight infants can prevent hemolytic anemia caused by vitamin E deficiency, and can reduce the formation of retrobulbar fibrous tissue (which can cause blindness) and bronchial-pulmonary system dysplasia caused by oxygen poisoning. However, some people believe that the above effects need further research and confirmation. 3. For the adjuvant treatment of progressive muscular dystrophy.
Vitamin E soft capsules
Indication: 1. For newborns, premature infants, and low birth weight infants born to mothers who do not eat fortified milk powder or have severe fat malabsorption. 2. Routine use of this product in immature infants and low birth weight infants can prevent hemolytic anemia caused by vitamin E deficiency, and can reduce the formation of retrobulbar fibrous tissue (which can cause blindness) and bronchial-pulmonary system dysplasia caused by oxygen poisoning. However, some people believe that the above effects need further research and confirmation. 3. For the adjuvant treatment of progressive muscular dystrophy.
Manufacturer:

Zhejiang Qianyuan Haili Sheng Pharmaceutical Co., Ltd.

Vitamin E soft capsules
Indication: 1. For newborns, premature infants, and low birth weight infants born to mothers who do not eat fortified milk powder or have severe fat malabsorption. 2. Routine use of this product in immature infants and low birth weight infants can prevent hemolytic anemia caused by vitamin E deficiency, and can reduce the formation of retrobulbar fibrous tissue (which can cause blindness) and bronchial-pulmonary system dysplasia caused by oxygen poisoning. However, some people believe that the above effects need further research and confirmation. 3. For the adjuvant treatment of progressive muscular dystrophy.
Vitamin E soft capsules
Indication: 1. For newborns, premature infants, and low birth weight infants born to mothers who do not eat fortified milk powder or have severe fat malabsorption. 2. Routine use of this product in immature infants and low birth weight infants can prevent hemolytic anemia caused by vitamin E deficiency, and can reduce the formation of retrobulbar fibrous tissue (which can cause blindness) and bronchial-pulmonary system dysplasia caused by oxygen poisoning. However, some people believe that the above effects need further research and confirmation. 3. For the adjuvant treatment of progressive muscular dystrophy.
Manufacturer:

Changchun Norman Bethune Pharmaceutical Co., Ltd.

Vitamin E soft capsules
Indication: 1. For newborns, premature infants, and low birth weight infants born to mothers who do not eat fortified milk powder or have severe fat malabsorption. 2. Routine use of this product in immature infants and low birth weight infants can prevent hemolytic anemia caused by vitamin E deficiency, and can reduce the formation of retrobulbar fibrous tissue (which can cause blindness) and bronchial-pulmonary system dysplasia caused by oxygen poisoning. However, some people believe that the above effects need further research and confirmation. 3. For the adjuvant treatment of progressive muscular dystrophy.
Manufacturer:

Beijing Baihui Biochemical Pharmaceutical Co., Ltd.

Vitamin E soft capsules
Indication: 1. For newborns, premature infants, and low birth weight infants born to mothers who do not eat fortified milk powder or have severe fat malabsorption. 2. Routine use of this product in immature infants and low birth weight infants can prevent hemolytic anemia caused by vitamin E deficiency, and can reduce the formation of retrobulbar fibrous tissue (which can cause blindness) and bronchial-pulmonary system dysplasia caused by oxygen poisoning. However, some people believe that the above effects need further research and confirmation. 3. For the adjuvant treatment of progressive muscular dystrophy.
Vitamin E soft capsules
Indication: 1. For newborns, premature infants, and low birth weight infants born to mothers who do not eat fortified milk powder or have severe fat malabsorption. 2. Routine use of this product in immature infants and low birth weight infants can prevent hemolytic anemia caused by vitamin E deficiency, and can reduce the formation of retrobulbar fibrous tissue (which can cause blindness) and bronchial-pulmonary system dysplasia caused by oxygen poisoning. However, some people believe that the above effects need further research and confirmation. 3. For the adjuvant treatment of progressive muscular dystrophy.
Manufacturer:

Guangdong Guangfa Pharmaceutical Co., Ltd.

Vitamin E soft capsules
Indication: 1. For newborns, premature infants, and low birth weight infants born to mothers who do not eat fortified milk powder or have severe fat malabsorption. 2. Routine use of this product in immature infants and low birth weight infants can prevent hemolytic anemia caused by vitamin E deficiency, and can reduce the formation of retrobulbar fibrous tissue (which can cause blindness) and bronchial-pulmonary system dysplasia caused by oxygen poisoning. However, some people believe that the above effects need further research and confirmation. 3. For the adjuvant treatment of progressive muscular dystrophy.
Manufacturer:

Guangxi Gehongtang Fanglue Pharmaceutical Co., Ltd.

Vitamin E soft capsules
Indication: 1. For newborns, premature infants, and low birth weight infants born to mothers who do not eat fortified milk powder or have severe fat malabsorption. 2. Routine use of this product in immature infants and low birth weight infants can prevent hemolytic anemia caused by vitamin E deficiency, and can reduce the formation of retrobulbar fibrous tissue (which can cause blindness) and bronchial-pulmonary system dysplasia caused by oxygen poisoning. However, some people believe that the above effects need further research and confirmation. 3. For the adjuvant treatment of progressive muscular dystrophy.
Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.